{"slug":"gilead-sciences","name":"길리어드 사이언스","name_en":"Gilead Sciences","ticker":"GILD","updated_at":"2026-07-11T10:20:17.555+00:00","canonical":"https://valuechain.wiki/gilead-sciences","kicker":"헬스케어 · S&P 500","kicker_en":"Health Care · S&P 500","lead":"에이즈와 간염 치료제를 개발하는 바이오제약 기업으로 항바이러스제 분야를 선도한다. S&P 500 구성종목. 섹터: 헬스케어(Biotechnology). 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A biopharmaceutical company developing HIV and hepatitis therapies, leading the antiviral drug field. S&P 500 constituent. Sector: Health Care (Biotechnology). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"HIV 치료제"},{"name":"간질환"},{"name":"항암(세포치료·온콜로지)"}],"total":"약 $28.8B (FY2024)"},"segments_en":{"parts":[{"name":"HIV"},{"name":"Liver Disease"},{"name":"Oncology & Cell Therapy"}],"total":"~$28.8B (FY2024)"},"returns_yearly":{"2021":30,"2022":23.6,"2023":-2,"2024":18.7,"2025":36.6,"2026":7.1},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}